Document is current
Any future updates will be listed below
-
Authors
Focke, Jan K. https://orcid.org/0000-0001-8014-5063
Brokbals, Mosche https://orcid.org/0009-0005-0493-6409
Becker, Jana
Veltkamp, Roland https://orcid.org/0000-0002-0583-1300
van de Beek, Diederik
Brouwer, Matthijs C.
Westendorp, Willeke F.
Kraemer, Markus https://orcid.org/0000-0002-5667-3621
-
Funding
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
- License Information
-
More Information
Article History
Received: 19 October 2024
Revised: 12 December 2024
Accepted: 15 December 2024
First Online: 15 January 2025
Declarations
:
: Roland Veltkamp reports grants from Boehringer Ingelheim; grants from Medtronic; grants from Daiichi Sankyo Company; compensation from Portola Pharmaceuticals for end point review committee services; compensation from Bristol Myers Squibb for consultant services; grants from Bayer; grants from Bristol Myers Squibb; compensation from Daiichi Sankyo Company for consultant services; compensation from AstraZeneca for consultant services; and compensation from Javelin Ventures for consultant services. All other authors report no conflicts.
: Due to its retrospective nature this study was conducted only on already existing data. The study was conducted in accordance with local ethical requirements.
